Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL-Reference-Cited by-同舟云学术

Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL

Published:2010-04 Issue:2 Volume:149 Page:237-243
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Linch David C.,Yung Lynny,Smith Paul,Maclennan Ken,Jack Andrew,Hancock Barry,Cunningham David,Hoskin Peter,Qian Wendi,Holte Harald,Boesen Anne-Marie,Grigg Andrew,Browett Peter,Trneny Marek

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08081.x/fullpdf

Reference24 articles.

1. Sequential high dose chemotherapy as initial treatment for aggressive subtypes of non-Hodkin Lymphoma: results of the international randomised Phase III trial (Mistral);Betticher;Annals of Oncology,2006

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma;Coiffier;New England Journal of Medicine,2002

3. Long-term results fo the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte;Feugier;Journal of Clinical Oncology,2005

4. Comparison of a standard regimen (CHOP) with three intensive regimens for advanced non-Hodgkin’s lymphoma;Fisher;New England Journal of Medicine,1993

5. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma;Gianni;New England Journal of Medicine,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments over the last 60 years in diffuse large B‐cell lymphomas;British Journal of Haematology;2020-11

2. Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial;Annals of Oncology;2020-09

3. High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma;Medicina Clínica;2020-09

4. High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma;Medicina Clínica (English Edition);2020-09

5. RETRACTED ARTICLE: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey;International Journal of Hematology;2019-11-16